International comparison of medicines approvals in the UK: a retrospective analysis

A retrospective analysis of medicines approvals in the UK, in comparison with other global regulators, to give an overview of the regulatory landscape in the UK before the implementation of the MHRA’S International recognition procedure (IRP) which may inform the IRP’s potential impact on access to innovative medicines.